Frédéric Bouisset

Interventional cardiologist / Cardiologist
Hopital de Rangueil CHU Toulouse - Toulouse, France

Latest contributions

Asymptomatic high-risk patients: can CT coronary angiography improve our practice?

21 May 2026 – From EuroPCR 2026

This session examines the role of cardiac computed tomography (CT) coronary angiography in improving clinical practice for asymptomatic high-risk patients. It discusses detection of vulnerable plaque features, the importance of inflammation and physiology in risk assessment, and explores individualized treatment pathways including PCI, medical therapy, or...

Ambiguous left main lesions: how to assess severity and make the right decision

21 May 2026 – From EuroPCR 2026

Addressing the complexities of ambiguous left main coronary lesions, this session elucidates the integration of physiology, intracoronary imaging, and CT scanning for comprehensive assessment. It highlights multimodality diagnostic strategies and decision-making frameworks to guide appropriate revascularization.

When the angiogram shows no answer for your AMI patient: what's next?

20 May 2026 – From EuroPCR 2026

This session focuses on non-occlusive causes of acute coronary syndromes (ACS) when angiograms do not reveal clear pathology. It emphasizes the diagnostic value of intracoronary imaging for conditions such as MINOCA and spontaneous coronary artery dissection (SCAD), and discusses optimal treatment strategies and prognostic considerations.

Artificial intelligence-powered precision: CT-guided PCI and the future of image-guided therapy

19 May 2026 – From EuroPCR 2026

Image-guided PCI is entering a new era, driven by artificial intelligence and advanced CT technologies that are reshaping how coronary interventions are planned and performed.

This EuroPCR 2026 session explores the integration of photon-counting CT into PCI workflows, highlighting its improved spatial resolution, enhanced plaque characterisation and...

Artificial intelligence-powered precision: CT-guided PCI and the future of image-guided therapy

Physiology in the real world: how to measure, when to trust it, what to do?

18 May 2026 – From EuroPCR 2026

This session provides comprehensive insights into coronary physiology assessment tools, emphasizing techniques for reliable haemodynamic measurements and exploring clinical considerations surrounding coronary spasms and myocardial bridges.

Once you find microvascular disease, what do you actually do?

18 May 2026 – From EuroPCR 2026

Addressing coronary microvascular disease requires a comprehensive understanding of current medical therapies and emerging interventions. This session reviews state-of-the-art pharmacological treatments, elucidates the mechanisms and clinical data surrounding the coronary sinus reducer (CSR), and offers critical discussion on its therapeutic role in microvascular dysfunction.

Novel Hertz Contact Intravascular Lithotripsy: could we achieve more in calcium modification?

22 May 2025 – From EuroPCR 2025

Discover how the novel Hertz Contact Intravascular Lithotripsy (IVL) is pushing the boundaries of calcium modification in challenging coronary lesions.

This EuroPCR 2025 session shares real-world insights confirming the promising results of the PINNACLE I trial, with LithiX IVL proving safe and effective across eccentric, concentric, and...

Novel Hertz Contact Intravascular Lithotripsy: could we achieve more in calcium modification?

Coronary physiology: FFR and beyond

22 May 2025 – From EuroPCR 2025

Advance your understanding of coronary physiology with a focus on fractional flow reserve (FFR) and beyond. This session covers randomized trials comparing physiology-guided treatment to standard care in ANOCA, graft patency related to quantitative flow ratio, impacts of microvascular dysfunction on patient outcomes, and prognostic value...

Coronary physiology: FFR and beyond

Integrating CT coronary angiography into your PCI practice

22 May 2025 – From EuroPCR 2025

Integrate CT coronary angiography into your PCI practice to enhance procedural planning and outcomes. This session covers practical CT-based approaches for guiding catheter selection, lesion analysis, and stenting strategy. Learn how to leverage CT imaging to anticipate plaque preparation needs in calcified lesions and optimize catheterization...

Integrating CT coronary angiography into your PCI practice

New perspectives in 3D calcium visualisation with CT and angiography for complex PCI

21 May 2025 – From EuroPCR 2025

Thanks to this EuroPCR 2025 session, discover new perspectives on 3D calcium visualisation combining advanced imaging techniques like 3DStent, IVUS, and 3D angiography to enhance complex PCI. Learn from detailed calcium mapping and plaque assessment to guide strategic decisions and see these innovations applied in practice...

New perspectives in 3D calcium visualisation with CT and angiography for complex PCI

EuroPCR 2023 Hotlines/Late-Breaking Trials: from (N)STEMI to Chronic Coronary Syndromes (CCS)

19 May 2023 – From EuroPCR 2023

What are the most significant facts in this respect? Get the essentials by listening to the presenters review some clinical hotlines. To cite a few, Selective Intracoronary hypothermia in anterior wall myocardial infarction; real-time catheter-based microvascular obstruction detection in STEMI : results from the MOCCA I...

from (N)STEMI to Chronic Coronary Syndromes (CCS)

Unusual NSTEMI

18 May 2023 – From EuroPCR 2023

Embark on an exploration of unusual NSTEMI cases, where extraordinary interventions and innovative approaches redefine patient care: witness the life-saving use of ECMO in acute coronary occlusion and cardiac arrest, delve into the complexities of multivessel PCI in patients with global vascular disease and renal dysfunction,...

Unusual NSTEMI